Loading chart…
CLOSED
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company offers its products in various dosage forms, including tablets, capsules, and solid orals. It provides various products for cardiovascular and hypertension, potent oncology, anti-infectives, central nervous system, and diabetic related diseases, as well as provision of contract research and manufacturing services.
Bafna Pharmaceuticals Limited (BAFNAPH) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The BAFNAPH share price is ₹472.80 (+4.03% today), with a market capitalisation of ₹11B and a price-to-earnings (P/E) ratio of 143.7. MarketRipple tracks the BAFNAPH investment thesis, the ripple-chain impact of market events on Bafna Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹472.80
High
₹472.80
Low
₹472.80
Prev. Close
₹454.50
52W High
₹479.95
52W Low
₹94.77
Day range
₹472.80–₹472.80
52-week range
₹94.77–₹479.95
Volume
445
P/E
143.7
ROE
11.5%
D/E
0.39
Margin
5.5%
Bafna Pharmaceuticals Limited (NSE: BAFNAPH) is currently trading at ₹472.80 (+4.03%).
Bafna Pharmaceuticals Limited's market capitalization is ₹11B.
Bafna Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 143.7.
Bafna Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).